Harbor Capital Advisors’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-279,820
| Closed | -$1.79M | – | 731 |
|
|
2024
Q1 | $1.79M | Sell |
279,820
-28,682
| -9% | -$183K | 0.23% | 101 |
|
|
2023
Q4 | $1.99M | Buy |
308,502
+22,437
| +8% | +$144K | 0.38% | 66 |
|
|
2023
Q3 | $667K | Buy |
286,065
+41,524
| +17% | +$96.8K | 0.14% | 178 |
|
|
2023
Q2 | $582K | Buy |
244,541
+22,392
| +10% | +$53.3K | 0.12% | 208 |
|
|
2023
Q1 | $409K | Buy |
222,149
+76,834
| +53% | +$141K | 0.12% | 158 |
|
|
2022
Q4 | $276K | Sell |
145,315
-3,139
| -2% | -$5.96K | 0.27% | 74 |
|
|
2022
Q3 | $318K | Sell |
148,454
-16,452
| -10% | -$35.2K | 0.29% | 71 |
|
|
2022
Q2 | $467K | Buy |
164,906
+1,763
| +1% | +$4.99K | 0.36% | 69 |
|
|
2022
Q1 | $680K | Sell |
163,143
-48,176
| -23% | -$201K | 0.32% | 73 |
|
|
2021
Q4 | $1.1M | Buy |
+211,319
| New | +$1.1M | 0.4% | 68 |
|